VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
92 hedge funds and large institutions have $1.06B invested in Verve Therapeutics in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 23 reducing their positions, and 22 closing their positions.
Holders
92
Holders Change
-3
Holders Change %
-3.16%
% of All Funds
1.46%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
19
Increased
39
Reduced
23
Closed
22
Calls
$212K
Puts
$1.25M
Net Calls
-$1.04M
Net Calls Change
-$792K
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$52.9M |
2 |
2
BlackRock
New York
|
$49.3M |
3 |
3
State Street
Boston,
Massachusetts
|
$60.8M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$22.4M |
5 |
PHS
5
PFM Health Sciences
San Francisco,
California
|
$8.44M |